Contract with Customer, Liability, Current of IDEXX LABORATORIES INC /DE from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
IDEXX LABORATORIES INC /DE quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Contract with Customer, Liability, Current for the quarter ending 30 Sep 2025 was $35,693,000, a 7.1% decline year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $35,693,000 -$2,741,000 -7.1% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $36,324,000 -$1,674,000 -4.4% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $35,000,000 -$3,193,000 -8.4% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $33,799,000 -$3,396,000 -9.1% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $38,434,000 +$1,152,000 +3.1% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $37,998,000 +$219,000 +0.58% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $38,193,000 +$354,000 +0.94% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $37,195,000 -$743,000 -2% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $37,282,000 -$3,527,000 -8.6% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $37,779,000 -$2,996,000 -7.3% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $37,839,000 -$3,066,000 -7.5% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $37,938,000 -$2,096,000 -5.2% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $40,809,000 -$319,000 -0.78% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $40,775,000 -$355,000 -0.86% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $40,905,000 -$734,000 -1.8% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $40,034,000 -$2,533,000 -6% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $41,128,000 -$1,471,000 -3.5% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $41,130,000 +$4,813,000 +13% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $41,639,000 +$3,611,000 +9.5% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $42,567,000 +$1,105,000 +2.7% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $42,599,000 -$387,000 -0.9% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $36,317,000 -$7,129,000 -16% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $38,028,000 -$5,323,000 -12% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $41,462,000 +$172,000 +0.42% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $42,986,000 +$1,837,000 +4.5% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $43,446,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $43,351,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $41,290,000 +$12,109,000 +41% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $41,149,000 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q4 2017 $29,181,000 31 Dec 2017 10-K 15 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.